Related Experiment Videos
Quantitative assessment of aortic sclerosis using ultrasonic backscatter
Doan T M Ngo1, Ronald D Wuttke, Stuart Turner
1The Queen Elizabeth Hospital, University of Adelaide, Woodville South, South Australia.
Summary
Ultrasonic backscatter intensity can quantify aortic sclerosis (ASC) severity, offering a more objective measure than current subjective evaluations. This method shows promise for monitoring disease progression and treatment response in aortic valve disease.
Area of Science:
- Cardiovascular Imaging
- Biomedical Engineering
- Valvular Heart Disease
Background:
- Aortic sclerosis (ASC) progression is difficult to assess due to subjective evaluation.
- Therapeutic interventions are more likely to be effective in preventing ASC progression than established aortic stenosis.
Purpose of the Study:
- To determine if ultrasonic backscatter intensity can objectively quantify sclerosis severity in the aortic valve.
- To compare backscatter values between patients with ASC, healthy adults, and patients with aortic stenosis.
Main Methods:
- Quantitative analysis of ultrasonic backscatter intensity from aortic valve leaflets.
- Regions of interest were placed on valve leaflets and blood pool to calculate calibrated backscatter values.
- Comparison of backscatter values in 26 ASC patients, 23 healthy controls, and 6 aortic stenosis patients.
Main Results:
- Mean backscatter values were significantly higher in sclerotic valves compared to normal valves (16.3 dB vs 9.8 dB).
- Aortic stenosis valves showed even higher backscatter values (22.0 dB).
- Backscatter magnitude correlated with subjective sclerosis scores and transvalvular pressure gradient, with good inter-observer and inter-examination reproducibility.
Conclusions:
- Ultrasonic backscatter measurement is a feasible method for quantifying aortic sclerosis severity.
- This technique may enable objective monitoring of ASC progression and treatment response.
- Provides a potential tool for evaluating therapeutic interventions in early aortic valve disease.